The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure

被引:12
|
作者
Norvell, Daniel C. [1 ]
Williams, Rhonda M. [2 ,3 ]
Turner, Aaron P. [2 ,3 ]
Czerniecki, Joseph M. [2 ,3 ]
机构
[1] Spectrum Res Inc, 705 S 9th St,Suite 203, Tacoma, WA 98407 USA
[2] VA Puget Sound Hlth Care Syst, Seattle, WA USA
[3] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA
关键词
Amputation; diabetes; peripheral arterial disease; patient-reported outcome; mobility; validity; QUALITY-OF-LIFE; LOWER-LIMB AMPUTATION; HEALTH-STATUS; PROSTHETIC PROFILE; PEOPLE; QUESTIONNAIRE; VALIDITY; VERSION; SCALES; INDEX;
D O I
10.1177/0269215516644308
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: This study describes the development and psychometric evaluation of a novel patient-reported single-item mobility measure. Design: Prospective cohort study. Setting: Four Veteran's Administration Medical Centers. Subjects: Individuals undergoing their first major unilateral lower extremity amputation; 198 met inclusion criteria; of these, 113 (57%) enrolled. Interventions: None. Main measures: The Amputee Single Item Mobility Measure, a single item measure with scores ranging from 0 to 6, was developed by an expert panel, and concurrently administered with the Locomotor Capabilities Index-5 (LCI-5) and other outcome measures at six weeks, four months, and 12 months post-amputation. Criterion and construct validity, responsiveness, and floor/ceiling effects were evaluated. Responsiveness was assessed using the standardized response mean. Results: The overall mean 12-month Amputee Single Item Mobility Measure score was 3.391.4. Scores for transmetatarsal, transtibial, and transfemoral amputees were 4.2 (+/- 1.3), 3.2 (+/- 1.5), and 2.9 (+/- 1.1), respectively. Amputee Single Item Mobility Measure scores demonstrated large and statistically significant correlations with the LCI-5 scores at six weeks (r=0.72), four months (r=0.81), and 12 months (r=0.86). At four months and 12months, the correlation between Amputee Single Item Mobility Measure scores and hours of prosthetic use were r=0.69 and r=0.66, respectively, and between Amputee Single Item Mobility Measure scores and Trinity Amputation and Prosthesis Experience Scales functional restriction scores were r=0.45 and r=0.67, respectively. Amputee Single Item Mobility Measure scores increased significantly from six weeks to 12months post-amputation. Minimal floor/ceiling effects were demonstrated. Conclusions: In the unilateral dysvascular amputee, the Amputee Single Item Mobility Measure has strong criterion and construct validity, excellent responsiveness, and does not exhibit floor/ceiling effects.
引用
收藏
页码:878 / 889
页数:12
相关论文
共 45 条
  • [31] Informing the development of an outcome set and banks of items to measure mobility among individuals with acquired brain injury using natural language processing
    Rehab Alhasani
    Mathieu Godbout
    Audrey Durand
    Claudine Auger
    Anouk Lamontagne
    Sara Ahmed
    BMC Neurology, 22
  • [32] Informing the development of an outcome set and banks of items to measure mobility among individuals with acquired brain injury using natural language processing
    Alhasani, Rehab
    Godbout, Mathieu
    Durand, Audrey
    Auger, Claudine
    Lamontagne, Anouk
    Ahmed, Sara
    BMC NEUROLOGY, 2022, 22 (01)
  • [33] The fibromyalgia-health index - (FM-HI): Development and validation of a novel, patient reported, fibromyalgia outcome measure
    Khosa, Shaweta
    Weinstein, Jennifer
    Seabury, Jamison
    Rosero, Spencer
    Varma, Anika
    Dilek, Nuran
    Engebrecht, Charlotte
    Heatwole, John
    Kaat, Aaron
    Heatwole, Chad
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [34] The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation
    Farber, Robert H.
    Stull, Donald E.
    Witherspoon, Brooke
    Evans, Christopher J.
    Yonan, Charles
    Bron, Morgan
    Dhanda, Rahul
    Jen, Eric
    Brien, Christopher O.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2024, 8 (01)
  • [35] The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation
    Robert H. Farber
    Donald E. Stull
    Brooke Witherspoon
    Christopher J. Evans
    Charles Yonan
    Morgan Bron
    Rahul Dhanda
    Eric Jen
    Christopher O.’ Brien
    Journal of Patient-Reported Outcomes, 8
  • [36] The Comprehensive High-level Activity Mobility Predictor-Sport (CHAMP-S): A Performance-Based Outcome Measure to Quantify High-level Mobility and Assist with Return to Sport for Division I Collegiate Football Players
    Gaunaurd, Ignacio A.
    Raya, Michele
    Feigenbaum, Luis
    Bennett, Christopher L.
    Viggiano, David
    Kaplan, Lee
    Gailey, Robert
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2017, 49 (05): : 117 - 118
  • [37] Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary
    Lipton, Richard B.
    Gandhi, Pranav
    Stokes, Jonathan
    Cala, Mary Lynn
    Evans, Christopher J.
    Knoble, Naomi
    Gelhorn, Heather L.
    Revicki, Dennis
    Viswanathan, Hema N.
    Dodick, David W.
    HEADACHE, 2022, 62 (01): : 89 - 105
  • [38] THE EXACT-PRO INITIATIVE: DEVELOPMENT AND VALIDATION OF A SINGLE PATIENT-REPORTED OUTCOME MEASURE FOR EVALUATING EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Leidy, N. K.
    Wilcox, T. K.
    Roberts, L.
    Winnette, R. M.
    Murray, L.
    VALUE IN HEALTH, 2008, 11 (06) : A454 - A454
  • [39] Development and initial validation of the Orthotic Patient-Reported Outcomes-Mobility (OPRO-M): An item bank for evaluating mobility of people who use lower-limb orthoses (vol 19, e0308468, 2024)
    Balkman, Geoffrey S.
    Bamer, Alyssa M.
    Stevens, Phillip M.
    Weber, Eric L.
    Morgan, Sara J.
    Salem, Rana
    Amtmann, Dagmar
    Hafne, Brian J.
    PLOS ONE, 2024, 19 (08):
  • [40] THE PD-HI: DEVELOPMENT AND VALIDATION OF A NOVEL, DISEASE-SPECIFIC PATIENT-REPORTED OUTCOME MEASURE FOR PARKINSON'S DISEASE CLINICAL TRIALS
    Seabury, J.
    Weinstein, J.
    Varma, A.
    Rosero, S.
    Engebrecht, C.
    Irwin, C.
    Shupe, C.
    Arky, A.
    Heatwole, J.
    Zizzi, C.
    Dilek, N.
    Purks, J.
    Adams, J.
    Dorsey, E. R.
    Heatwole, C.
    PARKINSONISM & RELATED DISORDERS, 2024, 122